the following are appropriate:	79
surveillance includes the following:	10
growth	9
neurologic	8
cardiac	8
appropriate surveillance includes:	8
appropriate surveillance includes the following:	7
other	7
musculoskeletal	7
eyes	6
ophthalmologic evaluation	6
cardiovascular	5
nutritional status	5
no clinical guidelines for surveillance are available	5
table 4	5
evaluation	5
skin	5
respiratory	5
hearing	4
annual	4
ophthalmologic examination	4
liver function tests	4
annual:	4
gastrointestinal	4
system	4
routine	4
dental	4
eye	4
or x	4
cbc	3
pulmonary function tests	3
surveillance should include annual neurologic examination	3
blood pressure	3
neurologic examination	3
hearing loss	3
regular follow up of ophthalmologic and/or audiologic abnormalities	3
ecg	3
the following should be performed on a regular basis:	3
ophthalmologic assessment	3
hearing evaluation	3
complete blood count	3
surveillance includes:	3
annual hearing evaluation	3
neurologic assessment	3
children	3
developmental progress	3
1 year	3
audiology evaluation	3
x(until normal)	3
skeletal assessment	2
there are no published guidelines for surveillance	2
annually	2
plasma amino acids	2
wilms tumor	2
routine visits to the neurologist are appropriate	2
rapid enlargement should prompt evaluation for possible hydrocephalus	2
no evidence for the efficacy of regular neuroimaging exists	2
skin should be examined at least annually	2
assessments of respiratory function to detect asymptomatic decline	2
inquire about frequency and severity of chest infections	2
the eeg at 24 months should be normal	2
there is no consensus on clinical surveillance	2
may be repeated as needed)	2
developmental and neurocognitive progress, as age-appropriate	2
audiologic assessment	2
eye examination	2
periodic assessment of bleeding and clotting parameters by a hematologist	2
follow up with an orthopedist when scoliosis becomes evident	2
affected individuals	2
measurement of blood pressure	2
endocrine	2
cognitive development	2
ophthalmologic	2
malignancy	2
sleep studies	2
brain mri	2
pulmonary	2
orthopedic	2
repeat audiometry to confirm stability of hearing loss	2
hepatic function	2
developmental and neurologic assessment	2
afp and hepatic sonography to monitor for hepatocellular carcinoma	2
cancer surveillance	2
pulmonary fibrosis	2
table 2	2
surveillance for individuals with the 7q11	2
23 duplication syndrome	2
test/measurement	2
monitoring of respiratory function	2
surveillance should be individualized based on symptoms and organs affected	2
recommended surveillance for individuals with ethylmalonic encephalopathy	2
frequency	2
hepatic function should be monitored every six to 12 months	2
recommended surveillance for individuals with fbxl4-related mtdna depletion syndrome	2
ent/mouth	2
skeletal	2
assessment for the following:	2
evaluation by an otolaryngologist for adenotonsillectomy	2
3 mmol/l	2
abdominal ultrasound examination	2
echocardiogram	2
nutritional assessment	2
pulmonary function testing	2
colon cancer	2
renal	2
urinary tract	2
adapted from gersh et al [2011]	2
contractures and/or scoliosis	2
recommended surveillance for individuals with kcnk9 imprinting syndrome	2
frequency/comment	2
every 6 months until age 2 years, then annually	2
at least annually	2
see thyroid evaluation	2
routine pediatric care	2
psychomotor development	2
biochemical investigations	2
yearly, beginning at the specified age:	2
pheochromocytoma	2
men 2a	2
fmtc	2
men 2b	2
urinalysis	2
the following are recommended:	2
clinical evaluations to characterize cchs phenotype based on phox2b variant	2
x 2	2
adapted from weese-mayer et al [2010]	2
, 20/24	2
nparm = non-polyalanine repeat expansion mutation (i	2
exogenous and endogenous gas challenges	2
comprehensive age-appropriate clinical autonomic testing	2
exon or whole-gene deletion or duplication	2
screening and surveillance guidelines for peutz-jeghers syndrome	2
8, 18 1	2
3 years 1	2
monthly	2
adapted from syngal et al [2015]	2
mre = magnetic resonance enterography	2
mrcp = magnetic resonance cholangiopancreatography	2
ct enterography may be used as an alternative	2
digital mammography if mri not available	2
discuss prophylactic mastectomy	2
discuss prophylactic hysterectomy and oophorectomy	2
recommended surveillance for individuals with ptls	2
dental evaluation	2
a child psychologist can assess cognitive & behavioral issues	2
recommended surveillance for individuals with pura-related neurodevelopmental disorders	2
the frequency has not been well established	2
biannual:	2
occupational therapy and physical therapy assessments	2
every four months until age four years	2
annually after age seven years	2
ongoing developmental assessments	2
table 3	2
afp = alpha-fetoprotein	2
alt/ast = alanine transaminase/aspartate transaminase	2
bun = blood urea nitrogen	2
cbc = complete blood count	2
ggt = gamma-glutamyl transferase	2
pt/ptt = prothrombin time/partial thromboplastin time	2
consultation with other specialists as applicable	2
surveillance for williams syndrome	2
renal and bladder ultrasound	2
except as noted	2
if normal, ogtt should be repeated every five years	2
audiometry	1
neuropsychological testing to establish functional level and learning capacities	1
blood tests	1
immunologic status, focusing on sle, is recommended	1
bone densitometry every two to five years to assess osteopenia	1
hbh disease	1
screening evaluations are likely to underestimate cognitive abilities	1
ophthalmologic examination is indicated:	1
every two to three years in adults	1
development	1
head growth and risk for hydrocephalus	1
craniocervical junction	1
sleep apnea	1
ears and hearing	1
kyphosis	1
legs	1
spinal stenosis	1
adaptation to difference	1
surveillance should be individualized using a multidisciplinary approach	1
individuals on ert also require periodic monitoring as follows:	1
plasma levels of peg-ada activity	1
erythrocyte daxp concentration	1
monitoring for the appearance or recurrence of dermatofibrosarcoma protuberans	1
ocular	1
serial evaluation of eegs to monitor disease progression is appropriate	1
in particular:	1
dental findings over time may warrant use of dental prosthetics	1
monitoring for signs of diabetes insipidus in the neonatal period	1
monitoring of the spine for the development of scoliosis	1
this should not be delayed unnecessarily	1
if puberty does start spontaneously it is likely to arrest	1
thus, careful monitoring of testosterone levels is needed	1
routine dermatologic evaluation to monitor for vascular and other malignancies	1
a few other countries have also initiated screening	1
note: serum α-fetoprotein measurement is not helpful	1
asymptomatic children at risk	1
less frequent intervals may also be appropriate	1
every 1-2 months in infants age ≤12 months	1
every 3-4 months in children age ≤10 years	1
urology	1
ochronotic prostate stones appear on radiography	1
primary care provider	1
neurologist	1
clinical geneticist	1
hepatologist or gastroenterologist	1
physiatrist	1
psychiatrist	1
ophthalmologist	1
pulmonologist	1
laboratory tests	1
every three months	1
urine analysis	1
serum concentration of lactic acid	1
biannually	1
urine organic acids	1
imaging and diagnostic procedures	1
liver ultrasound examination annually	1
eeg and video eeg monitoring (e	1
, for suspicion of subclinical status epilepticus	1
presence of epilepsia partialis continua	1
audiogram and brain stem auditory evoked responses as clinically indicated	1
barium swallow study as clinically indicated	1
clinical, neurologic, and neuropsychological follow up is necessary	1
specialized multidisciplinary als clinic evaluations are suggested every three months	1
pt/ot evaluation	1
speech evaluation	1
rod-cone dystrophy	1
obesity	1
progressive sensorineural hearing loss	1
audiometry should be performed yearly	1
cardiomyopathy	1
insulin resistance/type 2 diabetes	1
hyperlipidemia	1
renal disease	1
hepatic disease	1
pulmonary disease	1
hypothyroidism	1
patients should be monitored annually for thyroid abnormalities	1
monthly surveillance to identify and manage secondary complications is indicated	1
lifelong clinical follow up should include the following:	1
renal function monitoring by measurement of: blood pressure	1
body weight	1
serum concentrations of creatinine, albumin, and cholesterol	1
24-hour urinary protein	1
and creatinine clearance	1
agents/circumstances to avoid	1
evaluation of relatives at risk	1
pregnancy management	1
standard measures for prevention of fetopathy should be followed	1
these include:	1
possible changes of medication prior to pregnancy	1
appropriate measures include the following:	1
annual clinical examination for scoliosis	1
amblyopia and refractive error	1
detection of later-onset eye pathology	1
glaucoma	1
measurement of intraocular pressure	1
optic disc examination	1
visual field assessment, when possible	1
aniridic fibrosis syndrome	1
see wilms tumor overview	1
renal function	1
for asymptomatic persons, evaluate less frequently	1
routine visits to the attending neurologist are indicated	1
periodic assessment of the following:	1
bladder function	1
gait	1
sensation in the distal lower extremities	1
cognition (e	1
, executive function)	1
there are no formal guidelines regarding surveillance	1
the authors suggest obtaining the following:	1
counsel patients regarding the signs of liver dysfunction	1
no surveillance guidelines have been developed	1
monitor kidney function	1
facilitate medication compliance	1
periodic evaluation of liver function tests may be necessary	1
the appropriate frequency is unknown	1
periodic evaluation of serum electrolytes is appropriate	1
the frequency unknown	1
pulmonary follow up	1
increased vigilance for emphysema is appropriate	1
, serial radiographs to evaluate for progression of scoliosis	1
visual impairment appears to be progressive	1
thus, regular evaluation by an ophthalmologist is recommended	1
screening recommendations:	1
ecg, annually or more frequently depending on symptoms	1
echocardiogram, annually or more frequently depending on symptoms	1
holter monitoring, event monitoring, implantable loop recorder	1
exercise stress testing	1
cardiac mri, with frequency depending on symptoms and findings	1
periodic cbcs are warranted	1
, every 6 months), especially in children	1
ophthalmologic and audiologic examinations	1
bone densitometry to assess for osteoporosis in the adult	1
consensus management recommendations have not been established	1
uveal melanoma	1
malignant mesothelioma	1
no reliable early disease symptoms or screening modalities	1
cutaneous melanoma, basal cell carcinoma and atypical spitz tumors	1
clear cell renal cell carcinoma	1
early detection allows specific treatment of intraocular hypertension	1
routine follow up of deafness for any evidence of progression	1
screening for malignancies	1
suggested surveillance is summarized here:	1
routine (at least annual) measurement of blood pressure	1
annual endocrinology review	1
bethlem myopathy	1
ullrich cmd	1
once scoliosis is evident, regular orthopedic follow up	1
clinical assessment of nutritional status	1
kcnq2-bfne	1
kcnq2-nee	1
thorough neurologic and neuropsychiatric assessment is indicated annually	1
renal tumor screening	1
if any suspicious lesion (<1	1
renal tumors less than 3	1
0 cm in diameter are monitor by periodic imaging	1
melanoma	1
for all children with biotinidase deficiency:	1
regularly scheduled appointments with primary care physicians or as needed	1
monitor for changes related to the major findings over time	1
otologic anomalies	1
renal anomalies	1
regular assessment of renal function to prevent progression to esrd	1
follow-up ophthalmologic examination every one to two years	1
women	1
monthly breast self-examination	1
annual mammogram beginning at age 30	1
men	1
annual clinical breast examination beginning at age 35	1
annual prostate cancer screening beginning at age 45	1
women and men	1
periodic screening for glycosuria as a manifestation of diabetes mellitus	1
yearly cardiac ultrasound and ekg	1
yearly or biennial liver ultrasound examination to detect fatty infiltration	1
monitoring for hypoglycemia, especially in the neonatal period	1
otherwise, clinical examination alone was recommended	1
developmental screening as part of routine childcare	1
serum lactate and glucose	1
blood gases	1
liver parameters	1
and urine organic acids	1
there are no standard international surveillance guidelines for cadasil	1
consultation of other medical specialists (e	1
currently, no standard surveillance protocols exist	1
evaluation may be less often thereafter	1
monitoring for testicular abnormalities in males	1
monitoring fertility and metabolic risks in adults	1
fecundity and fertility	1
weight	1
lipid profile	1
bone mineral density	1
imaging studies	1
neonatal/infantile canavan disease	1
mild/juvenile canavan disease	1
annual routine follow up is indicated	1
pre-pubertal pediatric individuals	1
echocardiogram (annually	1
testicular ultrasound for boys	1
post-pubertal pediatric and adult individuals	1
testicular ultrasound (annually)	1
thyroid ultrasound (baseline examination	1
transabdominal ultrasound of the ovaries (baseline examination	1
urinary free cortisol levels (annually)	1
serum igf-1 levels (annually)	1
adrenal computed tomography	1
pituitary mri	1
three-hour oral glucose tolerance test (ogtt)	1
90-minute thyroid releasing hormone (trh) testing	1
periodic monitoring of the following is recommended:	1
respiratory function: spirometry	1
cardiac function: 24-hour electrocardiography and echocardiography	1
mobility and muscle function: physiatrist and physical therapist consultation	1
clinical evaluation should include assessment of:	1
growth including weight, linear growth, and head circumference	1
feeding ability	1
laboratory evaluation should include:	1
complete blood count (cbc) to monitor for cytopenias	1
routine evaluations should include:	1
brain mri and/or eeg as clinically indicated	1
annual evaluations including:	1
at least annual physical examination for evidence of kyphosis/scoliosis	1
children with ccd should be monitored for the following:	1
orthopedic complications	1
dental abnormalities	1
upper-airway obstruction	1
sinus and ear infections	1
osteoporosis	1
sleep studies especially when patients show signs of nocturnal hypoxia	1
thus far, heart valve dysplasia has not required correction	1
recommended monitoring for iron overload:	1
thyroid panel	1
annual gastrointestinal evaluation including monitoring of growth	1
routine monitoring of existing cardiac or renal anomalies	1
echocardiogram and electrocardiogram	1
perform annually during childhood and less frequently in adulthood	1
plasma carnitine concentration	1
serum ck concentration and liver transaminases	1
consider measuring during acute illnesses	1
annual ophthalmologic examinations starting at age four years	1
asymptomatic carriers	1
, abnormalities in cbc)	1
complete neurologic examination	1
hearing screen	1
whether this is related to ced is unknown	1
the authors are unaware of any other similar cases	1
monitor the following:	1
note: individuals receiving transfusion therapy need closer monitoring	1
hepatic function every six to twelve months	1
monitor for signs of precocious puberty	1
audiologic	1
annual evaluation of hearing is recommended	1
dermatologic	1
periodic evaluation for scoliosis during young childhood is recommended	1
cfeom is congenital and is believed to be non-progressive	1
and lung function tests, including fev1 and fvc	1
eeg approximately every third year	1
frequent clinical and radiologic dental evaluations should be performed	1
neurologic deficits	1
neurologic examination including assessment of memory, personality changes	1
psychiatric abnormalities	1
assessment for signs including depression and suicidal ideation	1
impaired respiratory function	1
sensorineural hearing loss	1
audiologic examination including speech discrimination testing	1
no guidelines for surveillance of classic chs exist	1
abdominal ultrasound examination to monitor for hepatosplenomegaly	1
cbc to evaluate for cytopenias	1
measurement of serum ferritin concentration	1
soluble interleukin-2 receptor measurement	1
skeletal dysplasia	1
anemia	1
immunodeficiency and infection	1
surveillance includes monitoring for evidence of scoliosis and its progression	1
, height, weight, and head circumference	1
plasma citrulline concentration	1
serum psti concentration	1
aro	1
the possible manifestations and complications of osteopetrosis require repeat investigations	1
adoii	1
periodic tests of hearing and vision	1
monitoring of the spine for the development of progressive kyphoscoliosis	1
routine surveillance of muscle strength and respiratory function is recommended	1
symptoms of nighttime hypoventilation should be considered	1
regular evaluations to determine:	1
need for change in diet to control weight	1
need to involve specialists to evaluate and treat potential complications	1
trpv4-associated neuromuscular disorders	1
ent consultation with laryngoscopy	1
dynamic breathing chest x-ray	1
hearing assessment	1
trpv4-associated skeletal dysplasias	1
annual assessment for the development of joint pain and scoliosis	1
a child reaches school age	1
surgical procedures involving general anesthesia	1
scoliosis needs to be closely followed	1
monitoring four times a year is recommended	1
yearly reassessment for known potential complications (e	1
, hypertension	1
renal or hepatic dysfunction	1
declining vision and hearing) is appropriate	1
growth and weight gain should be monitored	1
annual clinical evaluation is reasonable	1
hypoglycemia	1
however, studies are ongoing	1
bone density	1
six of 29 persons with the fgfr3 pathogenic variant p	1
for patients undergoing treatment:	1
perform neuropsychological assessment of cognitive functions and speech	1
monitoring should include:	1
in advanced disease (i	1
chest ct for detection of coronary and other vascular calcification	1
recommended annual surveillance includes the following:	1
neurologic and neuropsychologic evaluation	1
cholestanol plasma concentration	1
echocardiography	1
measurement of total body density (tbd)	1
these visits should include the following:	1
resting ecg	1
holter monitoring	1
echo and mri at least every two years	1
observation should include the following:	1
blood counts several times a year	1
plasma magnesium and potassium should also be assessed	1
adjustment of dosage may be required	1
dmd	1
bmd	1
evaluations should continue at least every two years	1
confinement to a wheelchair	1
reduction in vital capacity below 80% predicted	1
age 12 years	1
manual and mechanically assisted cough techniques	1
evaluation for surgical interventions as needed	1
an asymptomatic person with a known pathogenic variant	1
monitoring of seizure activity by regular neurologic examination and eeg	1
monitoring of orthopedic complications including foot deformity and scoliosis	1
annual audiologic assessment	1
sequential audiologic examinations are essential to:	1
document the stability or progression of the hearing loss	1
surveillance should include the following:	1
monitoring of height, weight, and bmi	1
clinical screening for scoliosis until the age of skeletal maturity	1
1, although screening intervals are not delineated	1
the following are also appropriate:	1
ongoing routine pediatric care	1
73 m2 (ckd stage 3b)	1
ent and audiology evaluations at least yearly	1
regular speech and language evaluation to monitor language development	1
annual examination by a physician familiar with hereditary hearing impairment	1
for individuals with nonsyndromic bilateral congenital hearing loss:	1
neonatal multisystem disease:	1
isolated hepatic disease	1
evidence of renal disease (proteinuria and aminoaciduria)	1
the following are indicated:	1
complete blood counts several times a year	1
monitoring of blood pressure in individuals who are steroid dependent	1
evaluation by an endocrinologist	1
cancer surveillance includes the following:	1
bone marrow failure	1
individuals on androgen therapy for bone marrow failure	1
perform liver ultrasound examination semiannually for adenomas	1
annual cancer screening by an otolaryngologist	1
annual gynecologic examination	1
annual skin cancer screening by a dermatologist	1
oral and dental surveillance	1
schedule routine screening and dental hygiene visits every six months	1
maintain good oral hygiene	1
urinalysis for microalbuminuria	1
ophthalmologic examination to screen for retinopathy	1
, at least every six months)	1
developmental assessment to identify any special educational needs is appropriate	1
sensory impairment	1
dementia	1
perform annual routine clinical testing for dementia:	1
observation of behavior	1
perform annual audiogram	1
frequent and serial monitoring is needed	1
the schedule should be determined by the findings present	1
treatments (e	1
surveillance is individualized based on disease progression	1
in those with cardiac malformations or conduction defects:	1
in those with renal anomalies:	1
the frequency depends on the clinical situation	1
0 mg/dl	1
periodic neurodevelopmental and/or developmental/behavioral assessments	1
interval/age	1
infancy	1
every 3 years	1
assessment of intellectual abilities & academic achievement	1
adolescents/adults	1
genetic counseling	1
monitoring and guidance as needed for educational and behavior problems	1
regular lifelong dietary evaluation to assure optimal nutritional status	1
regular lifelong evaluations of the following:	1
heart: based on the type of congenital anomaly	1
surveillance for infection and proper wound healing is indicated	1
radiographic surveillance by an orthopedist is appropriate	1
more advanced and invasive cardiac assessment may be required	1
routine examination for inguinal hernia and surgical referral as necessary	1
vigilant observation of blood pressure	1
evaluation/action	1
assess growth and monitor for failure to thrive	1
at each visit	1
monitor for epileptic crisis	1
modify therapy according to clinical presentation and eeg findings	1
annual mra from head to pelvis	1
regular examinations to address:	1
respiratory function	1
joint contractures and scoliosis	1
development or management of epileptic seizures	1
encroaching lesions and those causing symptoms may merit excision	1
annual evaluation with a multidisciplinary team including an endocrinologist	1
individuals receiving androgen therapy	1
liver function tests every three to six months	1
annual gynecologic assessment for genital lesions beginning at age 13	1
suspicious genital tract lesions should be biopsied	1
annual or more frequent renal function studies	1
annual cardiology evaluation	1
annual audiology evaluation	1
biennial brain mri/mra	1
assessment of ambulation, speech, and swallowing	1
regular review of communication needs and environmental adaptations	1
in individuals known to have fap	1
colonoscopy, once polyps are detected	1
spigelman staging criteria can help determine the frequency	1
non-fundic gland polyps should be removed endoscopically	1
thyroid cancer	1
annual abdominal palpation for desmoids	1
small-bowel polyps and cancer	1
screening for hepatoblastoma	1
efficacy in individuals with fap is unclear	1
adrenal tumors	1
in individuals who have undergone colectomy	1
in individuals known to have attenuated fap	1
colectomy	1
in individuals known to have gapps	1
no surveillance guidelines have been published	1
table 6	1
continued assessment of nutrition and growth	1
regular neurologic evaluations & developmental assessments	1
immunologic	1
monitoring for foot deformities and scoliosis	1
routine assessment of growth in children	1
follow-up frequency depends on findings	1
screening for sleep-disordered breathing with polysomnography	1
periodic assessment of psychomotor development and behavior in children	1
annual audiology evaluation for evidence of hearing loss in xlos	1
regular dental evaluations for individuals with xlos and ls	1
audiologic screening	1
blood pressure measurement and assessment of renal function	1
standard monitoring for renal anomalies	1
vertebral anomalies can lead to progressive scoliosis	1
orthopedic monitoring is therefore indicated	1
met694val pathogenic variant	1
papillomatosis	1
regular examinations	1
serum and csf folate concentrations	1
serum and csf homocysteine concentrations	1
routine care by a general pediatrician	1
curefa	1
org]	1
the following are appropriate	1
annual fasting blood sugar to monitor for diabetes mellitus	1
there are no specific surveillance guidelines for fryns syndrome	1
pain	1
respiratory dysfunction	1
no additional audiometry screening of asymptomatic individuals is necessary	1
ophthalmologic disease	1
annual dilated ophthalmoscopy in childhood is indicated	1
routine management of hormone deficiencies	1
chemotherapy and hematopoietic stem cell transplantation for acute myelogeneous leukemia	1
, absolute neutrophil counts above 0	1
5x109/l)	1
monitoring of growth in children and pubertal development in adolescents	1
biochemical profile including lipid profile	1
monitoring for development of varicose veins, especially in adults	1
monitoring for osteopenia/osteoporosis	1
no specific guidelines address the issue of surveillance	1
biochemical testing	1
, during the introduction of a new food)	1
values >78 mmol/mol creatinine are abnormal	1
schedule for individuals with classic or clinical variant galactosemia	1
biochemical genetics clinic visits	1
every six months during the second year of life	1
yearly thereafter	1
metabolic dietician clinic visits	1
ophthalmologic evaluations	1
speech evaluations	1
developmental evaluations	1
evaluations for premature ovarian insufficiency (poi)	1
evaluations for osteopenia	1
5 mg/100 ml in red blood cells	1
follow growth	1
monitor developmental milestones	1
propose supportive intervention as needed	1
the following should be monitored in persons with gan:	1
intellectual development/deterioration	1
the frequency of the monitoring should depend on disease progression	1
annual or more frequent evaluation is recommended	1
parenchymal abnormalities can be identified as well	1
screening for pulmonary hypertension	1
assessment of disease severity	1
annual multidisciplinary examination to assess:	1
height	1
joint range of motion by an orthopedist/physiotherapist	1
trachea for evidence of stenosis and respiratory compromise	1
liver size for evidence of hepatomegaly	1
blood measurement of ketone concentration is the preferred method	1
gm1 gangliosidosis	1
assessment of quality of life by a physiotherapist	1
yearly and before/after major medical events	1
monitoring of hip joint stability re risk of hip dislocation	1
seizures	1
yearly evaluation by a neurologist	1
mps ivb	1
assessment of quality of life by a physiotherapist:	1
yearly: track progress and optimize ambulation	1
cervical spine instability	1
neurologic examination every six months	1
mri neutral position: whole spine every year	1
these guidelines can be modified as appropriate	1
polysomnography if any clinical suspicion exists	1
slit lamp examination of cornea	1
examination of the posterior segment	1
evaluation every six months	1
yearly audiogram	1
thyroid studies annually	1
reevaluation of immunologic status between age nine and 12 months	1
annual complete blood count and differential	1
repeat audiology evaluation in infancy and prior to school enrollment	1
routine surveillance for the development of scoliosis	1
ongoing pediatric care with regular immunizations	1
monitoring for symptoms (e	1
routine monitoring of cardiac abnormalities	1
in severe cases, monitoring by a vascular surgeon	1
developmental surveillance should be conducted in all affected children	1
surveillance of the liver may include the following:	1
when hepatic adenoma is detected	1
any imaging performed for liver surveillance (e	1
cardiovascular surveillance	1
close follow up is indicated	1
chest x-rays at regular intervals	1
yearly or more frequently as indicated	1
this may include assessment for scoliosis and bone densitometry	1
regular nutritional and feeding assessment	1
periodic echocardiography	1
the following are appropriate annually:	1
measurement of height and weight to monitor growth	1
laboratory studies: lfts, ck, lipid profile	1
echocardiogram to monitor for cardiomyopathy	1
bone density measurements are recommended after growth is complete	1
annual routine physical examination	1
annual review of diet	1
height and weight should be measured annually to monitor growth	1
bone density determinations are recommended after growth is complete	1
liver phk deficiency	1
liver imaging	1
follow-up echocardiogram	1
no guidelines established	1
muscle phk deficiency	1
nutrition and swallowing should be monitored	1
onset of seizures and need for antiepileptic therapy	1
need for physical therapy to minimize contractures and maintain locomotion	1
clinical hfe-hh	1
this may be accompanied with measurement of alpha fetoprotein	1
01 kpa [friedrich-rust et al 2008]	1
biochemical hfe-hh	1
non-expressing p	1
cys282tyr homozygotes	1
general health should be closely followed	1
imaging allows:	1
assessment of spleen size to indirectly follow ph	1
visualization of bile duct abnormalities (e	1
physical therapy assessment for muscle weakness or contractures	1
blood test:	1
complete blood count with differential	1
gastric cancer	1
several screening modalities have been tested:	1
endoscopy	1
endoscopy permits direct inspection and biopsy of suspicious areas	1
the submucosal lesions are difficult to identify	1
further research is needed to evaluate this possibility	1
69 of 99 (70%) endoscopies were normal	1
lobular breast cancer (lbc)	1
lehman 2006	1
schelfout, personal communication]	1
annually:	1
lipid profiles	1
dental examination, x-ray, and cleaning	1
complete ophthalmologic examination with special attention to possible exposure keratopathy	1
reevaluation for cerebral avm	1
childhood	1
, pneumatocoeles) have formed	1
the following are recommended annually after hct:	1
neuropsychological evaluation	1
uterus	1
caution: ultrasound examination alone is never sufficient	1
liver function	1
electrolytes	1
calcium, magnesium, and phosphate concentrations	1
and iron status	1
trace metal supplements are provided as needed	1
treatment may need to be discontinued if:	1
white blood count <3	1
5x10^9/l	1
neutrophils <2	1
0x10^9/l	1
platelets <150x10^9/l	1
toxicity of iron supplementation	1
endometrial cancer	1
ovarian cancer	1
gastric and duodenal cancers	1
distal small bowel	1
other cancers	1
complications should be promptly addressed with appropriate therapy	1
vitamin b12 and folate levels should be monitored	1
renal ultrasound should be performed annually	1
pulmonary function testing should be performed annually in adults	1
colitis	1
colonoscopy is used to confirm the diagnosis	1
uterine tumors have only been reported in adults	1
surveillance can begin at reproductive age	1
cardiology visit with echocardiogram	1
pulmonary clinic visit with pulmonary function testing	1
audiogram	1
developmental assessment	1
sleep study for obstructive sleep apnea	1
ncv study for evidence of carpal tunnel syndrome	1
head/neck mri to document ventricular size and cervicomedullary narrowing	1
opening pressure on lumbar puncture	1
orthopedic evaluation to monitor hip disease	1
individuals with known ahus	1
note: individuals with esrd usually do not relapse	1
for relatives at risk for hcm	1
because penetrance of diagnostic features (i	1
age	1
screening guideline	1
<12 yrs	1
optional unless any of the following are present:	1
12-18 yrs	1
repeat evaluation every 12-18 months	1
>18-21 yrs	1
competitive athlete in intense training program	1
symptoms	1
other clinical findings that suggest early lvh	1
permanent weakness requires continuous medication, eg	1
the value should be between 3	1
0 and 3	1
5 mmol/l	1
annual monitoring of thyroid function is appropriate	1
1 mmol/l) is relatively specific for fh	1
during treatment, individuals of any age with:	1
fh should have lipid levels monitored as recommended	1
surveillance includes periodic:	1
neurologic evaluation to identify neurologic complications	1
social adjustment should be monitored	1
monthly until age three to four months	1
every three months between ages four months and one year	1
every six months between ages one and three years	1
annually after age three years	1
ongoing evaluation by a pedodontist or dentist is appropriate	1
routine monitoring:	1
annual routine follow-up with the multidisciplinary team is recommended	1
at periodic intervals:	1
echocardiogram and ekg to monitor for evidence of cardiomyopathy	1
pulmonary function studies	1
monitoring of behavior and mental status	1
in intervals between ane events neurologic function is stable	1
repeat pituitary mri	1
persons with acromegaly	1
persons with hypogonadism	1
follow established guidelines	1
recommendations follow	1
more data are needed to develop appropriate future guidelines	1
adults	1
baseline	1
thereafter	1
perform annual clinical assessment and pituitary function tests	1
yearly beginning at age four years	1
measure height and weight with calculation of height velocity	1
document pubertal development, tanner stages	1
perform pituitary function tests (as for adults)	1
perform baseline pituitary mri at about age ten years	1
degree of spasticity and related complications, including scoliosis	1
periodic sleep studies	1
neuropsychological and developmental evaluation and testing, as appropriate	1
these symptoms may warrant additional screening	1
if negative, screening should be repeated in three years	1
population	1
the following are recommended for individuals with ks:	1
evaluation of developmental milestones at each well child visit	1
referral for formal developmental evaluation if delays are identified	1
annual monitoring of vision	1
expectant monitoring for otitis media in children	1
the following should be assessed annually:	1
thyroid function	1
cardiac function if malformations are present	1
renal function if hydronephrosis or multiple renal cysts are present	1
table 5	1
evaluation of nutritional status & growth	1
evaluation of feeding difficulties	1
sleep study (if history of sleep disturbance)	1
evaluate for scoliosis	1
every 6 months until age 2 years	1
bfne	1
bfie	1
the eeg at 36 months should be normal	1
appropriate measures include:	1
strength testing (annually)	1
pulmonary function tests (annually in advanced cases)	1
cardiac and renal/urologic abnormalities should be monitored as needed	1
bone age determinations	1
the following should be assessed at least annually:	1
vision, hearing	1
yearly audiometry and endocrinologic evaluation	1
evaluation by a child neurologist at regular intervals is appropriate	1
special attention should be paid to growth and nutritional status	1
chronic diarrhea or failure to thrive could indicate malabsorption	1
special attention should be paid to nutritional status	1
chronic diarrhea or weight loss could indicate malabsorption	1
both children and adults	1
consensus on optimal screening protocols has not been published	1
lbsl is very slowly progressive in most cases	1
annual clinical evaluations suffice	1
rarely, vision appears to improve beyond expectations	1
in such cases, a repeat erg is indicated	1
standard surveillance includes the following:	1
routine history re signs and symptoms of seizures	1
monitoring for orthopedic complications such as foot deformity and scoliosis	1
frequency depends on the severity	1
the following is recommended:	1
the following is suggested:	1
monitoring of the airway and vocal cords by an otolaryngologist	1
no surveillance guidelines for lms have been published	1
monitor plasma uric acid concentration and urinary excretion of oxypurines	1
monitor affected individuals for early signs of self-injury	1
no formal guidelines exist	1
monitoring should include the following:	1
fasting and postprandial blood ammonia concentrations	1
urinary orotic acid excretion	1
evaluation of renal function	1
attention to early clinical signs of lung involvement	1
serum concentrations of ldh and ferritin	1
no specific guidelines have been proposed	1
repeat imaging of:	1
gastrointestinal tract	1
cardiovascular system	1
regular pediatric care	1
individuals with biallelic germline	1
in europe:	1
registration or institutional access required):	1
pan colonoscopy beginning at age 18-20 years	1
individuals heterozygous for a germline	1
fibrous dysplasia	1
endocrinopathies	1
precocious puberty	1
thyroid	1
see gonadal involvement management in boys	1
growth hormone excess	1
see growth hormone excess evaluation:	1
all children should be monitored for growth acceleration	1
fgf23-mediated phosphate wasting	1
hypercortisolism	1
routine biochemical surveillance is not indicated	1
see gastrointestinal management (pdf)	1
hemoglobin concentration	1
serum concentrations of uric acid and creatinine	1
measurement of serum uric acid concentration at least annually	1
one individual with mls developed life-threatening rhabdomyolysis	1
early-onset lama2 md	1
annual measurement of fvc to allow trending of fvc	1
at least annual evaluation of the spine by an orthopedist	1
cardiac monitoring:	1
late-onset lama2 md	1
monitor for respiratory insufficiency with serial pulmonary function tests	1
monitor to detect and treat seizures	1
routine developmental assessments	1
monitoring of specific identified medical issues	1
periodic:	1
renal structure/function	1
periodic monitoring of renal function	1
serum concentration of magnesium, potassium, uric acid	1
mody5	1
hgba1c annually	1
routine monitoring through early childhood	1
audiologic and ophthalmological evaluations on a regular basis	1
ongoing pediatric care	1
specialized neurologic care for individuals with epilepsy	1
monitoring for spine deformities	1
monitoring as needed of cardiac and renal/urologic abnormalities	1
routine developmental and learning assessments	1
monitoring of any specific medical issues that are identified	1
continued assessment of:	1
feeding and nutrition	1
developmental milestones	1
possible psychiatric manifestations	1
3 microdeletion until disproven otherwise	1
the following should be monitored from early childhood:	1
onset and frequency of seizures and response to antiepileptic medications	1
number and type of infections	1
autistic-like features	1
gastrointestinal symptoms	1
men1 minimal surveillance program	1
fasting serum gastrin concentration from age 20 years 2	1
imaging	1
every three to five years beginning at the specified age	1
head mri from age five years 2	1
abdominal ct or mri from age 20 years 2	1
notes:	1
serum concentration of prolactin from age five years	1
mtc	1
hypoparathyroidism	1
parathyroid adenoma or hyperplasia	1
electrocardiogram and/or echocardiogram yearly for early detection of cardiomyopathy	1
pulmonary function tests for individuals with exertional or nocturnal dyspnea	1
regular follow up with a child neurologist for seizure management	1
monitoring of head circumference and stature using standard growth charts	1
the following surveillance is appropriate:	1
surveillance as appropriate for each individual is recommended	1
annual ophthalmologic assessment should address possible ophthalmologic changes	1
annual follow up with a generalist is appropriate	1
plasma and urine mma levels	1
serum acylcarnitines and free and total carnitine levels	1
liver, kidney, and bone health	1
bone marrow indices	1
monitoring of respiratory function should include the following:	1
lung function tests (fev1 and fvc)	1
assessment of the need for intermittent or permanent ventilation	1
growth should be assessed regularly	1
regular neuromuscular evaluation to assess disease progress is indicated	1
breath test to screen for bacterial overgrowth is recommended	1
annual assessment of joints by a rheumatologist or orthopedic surgeon	1
additional recommendations include:	1
repeat electrocardiogram and echocardiogram if symptoms of cardiac insufficiency occur	1
however, recommended surveillance includes the following:	1
brain mri to detect hydrocephalus and/or cerebellar tonsillar ectopia	1
cardiac assessment including annual echocardiogram	1
developmental assessment in all patients	1
individuals on ert	1
physical and neurologic evaluation at least every six months	1
all individuals	1
optimize ambulation	1
pain severity assessment every six months	1
age-appropriate quality of life questionnaires every year	1
upper and lower extremities	1
, functional dexterity test) of the upper extremities	1
spine	1
, extremity weakness	1
clumsiness	1
unsteady, changing gait	1
evaluate heart rate annually	1
polysomnography every three years	1
monitor for vision and ocular abnormalities at every visit	1
refer to an ophthalmologist as needed	1
evaluate every six to 12 months	1
perform yearly audiogram	1
serum alpha fetoprotein (afp) concentration	1
developmental evaluation	1
urinalysis and urine amino acids to assess for renal tubulopathy	1
the following assessments are indicated:	1
, palmoplantar keratosis)	1
annual ophthalmologic examination is recommended	1
annual ophthalmologic exams for ophthalmoplegia, ptosis, and myopia	1
potential screening tests include the following:	1
annual blood counts [herman et al 1999]	1
regular developmental assessments of affected children	1
periodic repeat audiograms	1
periodic assessment for strabismus	1
monitoring for the development of otitis media (om)	1
regular developmental assessments to plan and refine educational interventions	1
every six months	1
every year	1
measurement of serum concentration of creatinine	1
every three years	1
audiometric evaluation	1
measurement of serum ast, alt and ggt	1
evaluation for upper airway stenosis (e	1
annual ophthalmologic and audiology evaluations	1
monitoring of physical skill development and joint mobility	1
gagnon et al [2010] provide guidelines for surveillance	1
annual ecg to detect asymptomatic cardiac conduction defects	1
ophthalmologic examination every two years to evaluate for cataract formation	1
annual measurement of the following is appropriate:	1
urine albumin:creatinine ratio on a first-morning urine	1
dental examination is indicated at least every six months	1
neurologic, ophthalmologic, and cardiologic evaluations are recommended	1
assessment of ambulation and speech abilities	1
this may include clinical surveillance for the following:	1
swallowing difficulties and recurrent aspiration	1
x-ray surveillance of hip joints and spine	1
monitoring of growth and development in infants and children	1
routine assessment for scoliosis and joint contractures	1
evaluations are recommended at least annually	1
monitoring of blood pressure, growth parameters, and development	1
urinalysis to monitor proteinuria	1
regular developmental assessment by screening questionnaire (in childhood)	1
regular blood pressure monitoring	1
other studies (e	1
it is not clear if earlier surveillance (i	1
breast self-examination and ultrasonographic evaluation recommended in affected females	1
carriers (heterozygotes)	1
parents	1
at-risk sibs	1
severely affected individuals should be monitored for scoliosis	1
observation for clinical evidence of venous stasis or ulcer disease	1
nutrition status	1
occupational and physical therapy needs	1
fatigue	1
bleeding, shortness of breath	1
abdominal pain	1
headaches	1
extremity pain	1
physical examination including assessment of neurologic function	1
pulmonary function testing and chest radiograph	1
nutrition assessment	1
sleep disturbances are common in npc	1
child syndrome	1
ck syndrome	1
neurologic surveillance of seizures for readjustment of medications if necessary	1
orthopedic surveillance for scoliosis/kyphosis	1
phox2b variant	1
annual in-hospital comprehensive testing 1	1
annual neurocognitive assessment	1
annual 72-hr holter and ecg	1
hirschsprung disease assessment	1
tumors of neural crest origin assessment	1
parm genotype:20/24, 20/25	1
parm genotype: 20/26, 20/27	1
parm genotype: 20/2820/33	1
nparm	1
x 3	1
deletion/ duplication 4	1
clinical evaluation for development of orthopedic manifestations (e	1
cardiac follow-up for those with cardiac defects	1
bleeding disorder	1
for menstruating females:	1
cardiac fibrosis	1
ghosh et al 2013	1
author, personal observation]	1
no disease-specific guidelines have been developed	1
follow up by an ophthalmologist to monitor vision	1
audiometric evaluation with periodic follow up	1
sdhc, sdhd,	1
monitoring includes the following:	1
in persons with sdhb pathogenic variants, periodic (e	1
hearing should be evaluated annually	1
annual ophthalmologic evaluation is indicated	1
visual field testing is much more helpful	1
coagulation factors and other synthetic liver functions should be monitored	1
persons with overt hepatic dysfunction require more routine monitoring	1
the use of routine neuroimaging is uncertain	1
individuals with peroxisomal disorders may develop a progressive leukodystrophy	1
monitor lactate levels regularly	1
regular assessments of intellectual function should be offered	1
semiannual or annual examination by an endocrinologist familiar with pds	1
regular developmental assessments	1
the patient's individual diagnosis and status	1
surveillance would follow the	1
guidelines for ipf [raghu et	1
al 2011] or the specific type of iip	1
those who are stable may be	1
pulmonary function studies including the following to serially monitor	1
disease course [raghu	1
et al 2011]:	1
forced vital capacity (fvc)	1
saturation change at baseline	1
monitoring for progression of disease by hrct of the chest	1
oxygen saturation by resting pulse oximetry	1
suspected of an underlying possibility for ctd-related ild	1
monitoring for any side effects known from pharmacologic treatments	1
symptom control	1
periodic monitoring for fat-soluble vitamin deficiency is recommended	1
preserved renal function (i	1
ongoing urinalysis (spot and 24-hour collections)	1
gfr <60 ml/min/1	1
gfr <30 ml/min/1	1
thyroid function testing	1
electrocardiogram to evaluate for an associated atrioventricular block	1
frequency of testing depends on the center	1
quarterly	1
six monthly to annually	1
24 hour urine oxalate and supersaturation study	1
during childhood:	1
annual screening for developmental delay or learning disorders	1
current suggested screening by age follows:	1
cowden syndrome	1
pediatric (age <18 years)	1
yearly skin check with physical examination	1
adult	1
yearly thyroid ultrasound** and dermatologic evaluation	1
women beginning at age 30 years:	1
monthly breast self-examination**	1
yearly breast screening (at minimum mammogram)	1
mri may also be incorporated	1
yearly transvaginal ultrasound or endometrial biopsy**	1
for men and women:	1
colonoscopy beginning at age 35 years**	1
frequency dependent on degree of polyposis identified	1
bannayan-riley-ruvalcaba syndrome	1
screening recommendations have not been established for brrs	1
proteus syndrome/proteus-like syndrome	1
mcap syndrome	1
a medical history with attention to:	1
childhood cancer	1
breathing or sleep problems	1
a detailed neurologic evaluation	1
renal ultrasound	1
cloves syndrome	1
therefore, diligent surgical care and monitoring are recommended	1
fibroadipose hyperplasia	1
site	1
procedure	1
age at initial screening (yrs)	1
interval	1
stomach	1
upper endoscopy	1
small intestine	1
capsule endoscopy or mre 2	1
8, 18 3	1
3 years	1
large intestine	1
colonoscopy	1
breast	1
breast self-examination	1
clinical breast exam	1
6 months	1
breast mri or digital mammography 4, 5, 6	1
ovary, cervix, uterus	1
transvaginal ultrasound & serum ca 125	1
pelvic exam w/pap smear 6	1
18-20	1
pancreas	1
mri-mrcp or endoscopic ultrasound	1
1-2 years	1
testes	1
testicular exam	1
ultrasound if symptomatic or abnormality on exam	1
birth to teenage years	1
oral assessment for consequences of trauma	1
swallowing evaluation and regular dietary assessments to assure adequate nutrition	1
early detection of hypertension	1
renal cell carcinoma	1
intracranial aneurysms	1
aortic dissection	1
cardiac valvular abnormalities	1
colon diverticulosis	1
mineral balance, monitored by assessing calcium and phosphorous	1
hydration status	1
agents to avoid	1
the following should be avoided:	1
for affected individuals with hypertension, sympathomimetic agents	1
potentially hepatotoxic agents (e	1
no long-term sequelae are associated with pnkd	1
monitoring medication requirements and dosage is appropriate	1
no general surveillance guidelines have been developed to date	1
monitoring should be individualized	1
surveillance is usually performed annually	1
comments	1
at every visit	1
ophthalmology evaluation	1
yearly	1
ent / mouth	1
newborn hearing screen, then as indicated for speech delay	1
every 6 months starting in early childhood	1
echocardiogram w/attention to aortic root dimension & ecg	1
every 3 yrs, if initial evaluations were normal	1
otherwise, as directed by cardiologist	1
monitoring for development of scoliosis	1
clinical examination at every visit	1
scoliosis survey if scoliosis is clinically suspected	1
referral to orthopedist if indicated	1
psychiatric	1
behavioral assessment	1
screen for behavior problems at every visit	1
miscellaneous / other	1
developmental monitoring by a developmental specialist	1
annually, or at frequency directed by developmental specialist	1
for short stature: consider endocrinology evaluation	1
ppb	1
thyroid gland neoplasia	1
thyroid physical examination in a patient of any age	1
ovarian stromal tumors	1
cbme	1
visual inspection of the eye and orbit	1
botryoid erms	1
ncmh	1
nasal endoscopy as warranted by ophthalmologic signs (e	1
pituitary blastoma	1
pineoblastoma	1
no specific guidelines for surveillance have been published	1
recommendations include the following:	1
abdominal ultrasound examination to assess liver and spleen size	1
follow up as recommended by a pulmonologist and immunologist	1
growth should be carefully monitored	1
clinical evaluation should include assessment of the following:	1
interval assessment for the need of g-tube	1
neurologic evaluation including survey for seizures and movement disorders	1
interval ophthalmologic evaluation including dilated eye examination	1
evaluation for clinical signs of cardiomyopathy (e	1
laboratory evaluation should include the following:	1
complete blood count and differential to monitor for cytopenias	1
renal function tests	1
amylase and lipase as needed to evaluate for pancreatitis	1
other evaluations:	1
dexa scan	1
brain mri, mrs, and eeg as clinically indicated	1
plasma xanthine is cleared efficiently and does not accumulate	1
symptomatic lower limb malalignment	1
evidence of kyphoscoliosis	1
symptoms related to joint hypermobility	1
(see prevention of primary manifestations	1
affected system	1
cognitive	1
monitoring by developmental pediatrics	1
long-term	1
eeg & video eeg monitoring	1
if seizures are suspected	1
ophthalmologic & vision evaluations	1
monitoring for dysphagia & constipation	1
monitoring for musculoskeletal complications including hip dysplasia & scoliosis	1
every month in infancy	1
every six months in the first decade of life	1
at least annually thereafter	1
cryptorchidism can recur after orchidopexy	1
therefore, testicular position should be monitored	1
obtain history of any sleep disturbance	1
if present, obtain a sleep study	1
obtain history for behavioral and psychiatric disturbance at least annually	1
regular examination by an ophthalmologist with expertise in retinal disease	1
regular physical examination with specific attention to the cardiovascular system	1
monitoring by the affected individual for black tarry stool	1
periodic monitoring of serum lipid concentrations	1
psychiatric symptoms	1
annual screening for developmental delays or learning disorders	1
annual cardiac examination to identify cardiomyopathy and concomitant arrhythmias	1
detection of subsequent rb after initial diagnosis	1
detection of second non-ocular tumors in individuals with retinoblastoma	1
older children and adults need less frequent monitoring	1
periodic ecg to screen for prolonged qtc	1
examination at regular intervals for the progression of scoliosis	1
general examination	1
discussion of any problems with riboflavin supplementation	1
alkaline phosphatase level	1
intact parathyroid hormone level	1
renal ultrasound examination to assess for nephrocalcinosis	1
the following evaluations should be considered:	1
regular assessments of neurodevelopment, speech, and language	1
rrm2b-related mitochondrial dna depletion syndrome and mitochondrial neurogastrointestinal encephalopathy	1
rrm2b-related multiple mtdna deletions with external ophthalmoplegia	1
care will be directed by clinical findings	1
the following general evaluations are recommended:	1
ecg advised biannually (kss phenotype)	1
monitoring of growth with special attention to growth velocity	1
close monitoring of speech and language development	1
annual follow-up evaluation for ophthalmologic abnormalities	1
yearly audiologic screens	1
monitoring as per routine for cardiac or renal anomalies	1
regular dental and orthodontic follow up	1
annual evaluation by a physician familiar with rts	1
monitoring of growth	1
doses should be altered as needed	1
monitor as follows:	1
complete blood count annually	1
annual evaluation of gait, coordination, and speech	1
small children	1
neurophysiologic studies when clinically indicated	1
brain mri every three to five years	1
adolescents and adults	1
neurologic examination annually	1
audiologic and ophthalmologic examinations every one to two years	1
eeg and brain mri at least during status epilepticus	1
neurologic evaluation every three to six months is appropriate	1
gait, coordination, and speech should be evaluated annually	1
periodic speech assessment if dysphagia becomes a problem	1
monitoring of speech and swallowing difficulties is recommended	1
surveillance of speech and ambulation	1
driving ability should be assessed by professionals periodically	1
routine visits to a neurologist are appropriate	1
monitor with eeg and other modalities (e	1
, headache, reduced school performance) are identified	1
audiologic screening throughout childhood is indicated	1
screen for sleep-disordered breathing at all visits	1
note: discussions to update and maintain recommendations are ongoing	1
for males with sgbs1:	1
monitoring for hypoglycemia in the newborn period	1
radiographs as needed	1
monitoring of renal function if renal anomalies are present	1
every three months until age four years	1
every four months from age four to seven years	1
biannually after age seven years	1
the following screening recommendations require further study to determine benefit	1
gonadoblastoma or hepatocellular carcinoma	1
every six months between ages four and seven years	1
neuroblastoma	1
every six months from age four to seven years	1
periodic hearing assessments in childhood	1
the following are general guidelines compiled from several sources	1
see published guidelines/consensus statements	1
comprehensive medical and social evaluation	1
routine dental care is recommended	1
mental health and neurocognitive assessment	1
annual laboratory assessment should include the following:	1
cbc with differential and reticulocyte count	1
assessment of iron status	1
ldh as a marker of hemolysis	1
vitamin d level	1
assessment of stroke risk	1
end-organ evaluation	1
chest x-ray examination	1
pulmonary function tests (pfts)	1
six-minute walk test	1
sleep study (to assess nighttime hypoxemia)	1
iron overload by mri	1
regular monitoring of the hips	1
annual monitoring of renal, immune, and hematologic status	1
routine monitoring of:	1
height and weight using age and gender appropriate growth charts	1
swallowing and diet to assure adequate nutrition	1
ambulation and speech	1
regular swallowing assessment to evaluate risk for aspiration	1
, a clinical geneticist)	1
affected children frequently die in infancy or early childhood	1
the following are indicated on a routine basis:	1
monitoring for scoliosis and kyphosis	1
individuals with sma are evaluated at least every six months	1
weaker children are evaluated more frequently	1
recommended annually:	1
thyroid function, including free t4 and tsh	1
fasting lipid profile	1
routine urinalysis to evaluate for occult urinary tract infections	1
monitoring for scoliosis	1
annually from infancy onwards for the following:	1
assessment for increased intracranial pressure and medullary compression	1
neurologic and otologic examination for consequences of cranial nerve entrapment	1
the following are appropriate at the clinical evaluation:	1
thorough history to identify known clinical sequelae of sotos syndrome	1
cardiac auscultation	1
blood pressure measurement	1
examination for curvature of the spine	1
urine dipstick to assess for quiescent urine infection	1
referral to the appropriate clinical specialist if problems are identified	1
note: cancer screening is not recommended	1
the following measures are suggested:	1
annual hearing test	1
neurodevelopmental assessment annually for the first five years of life	1
regular electrophysiologic investigations (e	1
cognitive testing	1
repeat skeletal survey	1
, contractures)	1
regular neurologic and developmental assessments are indicated	1
annual examination by a vitreoretinal specialist is appropriate	1
more advanced testing (e	1
neuropsychological assessment	1
eeg	1
routine developmental and neurologic assessment	1
periodic nutritional and growth assessment	1
periodic hearing evaluation	1
periodic ophthalmologic examination	1
nutritional and growth assessment	1
routine nutritional assessment is appropriate	1
routine screening for depression at clinic visits is appropriate	1
yearly dental evaluation is appropriate	1
annual hearing evaluation is indicated	1
routine assessment of neurologic status on physical examination	1
audiology assessment	1
eeg for seizure activity	1
regular orthopedic evaluations to monitor scoliosis or joint problems	1
soon after diagnosis is established:	1
for trps i and trps ii	1
monitor linear growth in childhood	1
routine developmental assessments in childhood	1
for trps ii only	1
regular dietary evaluation in infancy to ensure optimal nutritional status	1
monitoring of developmental progress and educational needs	1
monitoring for spine deformities beginning in early childhood	1
regular evaluation of teeth	1
frequency determined by a dentist based on dental condition	1
hematologic tests (cbc, reticulocyte count)	1
hearing test	1
cardiac evaluation	1
neurologic evaluation	1
at least yearly:	1
medical evaluation including physical examination to assess weight and medications	1
evaluation by orthopedists to assess for scoliosis and joint dislocation	1
annual neurologic evaluation to assess symptoms and any emerging complications	1
central nervous system	1
perform screening for tand features at least annually	1
perform detailed clinical dermatologic inspection/exam annually	1
initiation of therapy (baseline)	1
first 6 months:	1
after 6 months of rx: every 6-12 months	1
after 2 years of rx: every 6-12 months	1
as clinically indicated	1
every 3 months	1
tyrosinemia type i markers	1
plasma concentration of methionine, phenylalanine, tyrosine	1
blood / urine succinylacetone	1
x(urine)	1
blood nitisinone concentration	1
hemoglobin, hematocrit, wbc, platelet count	1
liver evaluation	1
serum afp concentration	1
pt/ptt	1
bilirubin	1
alt/ast/ggt	1
alkaline phosphatase	1
ct or mri 1	1
renal studies	1
bun / creatinine	1
urine: po4, ca, prot/cr ratio	1
skeletal evaluation	1
x-ray of wrist (for rickets)	1
annual evaluation with the following specialists is appropriate:	1
pediatrician for growth assessment	1
neurologist to identify and manage seizures	1
orthopedist for evaluation of contractures and back examination for scoliosis	1
ophthalmologist for ocular manifestations and corrective therapy if needed	1
annual blood pressure monitoring starting at age one year	1
monitoring for complications is as follows:	1
cns lesions	1
visceral lesions	1
annual abdominal ultrasound	1
retinal angiomas	1
endolymphatic sac tumors (elst)	1
the best way to detect elst is unknown	1
other guidelines originate from denmark and the netherlands	1
two recent studies evaluated tumor progression	1
measurement of immunoglobulin concentrations prior to ivig infusions	1
broncho-alveolar lavage to diagnose pneumocystis jirovecii infection	1
viral cultures or lung function studies as needed	1
cerebrospinal imaging to diagnose leukodystrophy when clinically indicated	1
click here for full text	1
neonatal period and infancy	1
otolaryngologic evaluation	1
audiologic evaluation	1
assessment of prelinguistic speech-language development	1
longitudinal evaluation and treatment	1
evaluations should be carried out routinely through adolescence	1
routine dental evaluation should continue throughout life	1
these evaluations should continue throughout adolescence	1
annual ophthalmologic examination by a vitreoretinal specialist is indicated	1
screening for type 2 diabetes mellitus at least annually	1
annual lipid profile	1
annual ophthalmologic examination for cataracts	1
wolfram syndrome	1
diabetes mellitus: tests of glucose tolerance	1
optic atrophy: ophthalmologic examination	1
sensorineural hearing loss: audiologic examination including speech discrimination testing	1
diabetes insipidus: assessment of concentrating ability of the urine	1
hypogonadism	1
puberty: monitoring for signs of onset of puberty	1
diabetic retinopathy	1
microalbuminuria	1
low-frequency sensorineural hearing loss (lfsnhl)	1
regular audiologic examination including speech discrimination testing is appropriate	1
complete blood count annually to evaluate for hematopoietic dysfunction	1
and creatinine clearance test	1
consideration of routine liver ultrasonography to evaluate for liver adenomas	1
interval / age	1
in infants – toddlers	1
annual / all ages 1	1
every 2 years	1
serum concentration of calciumthyroid function and tsh level	1
every 10 years	1
in adults	1
thyroid function test yearly until age 3 years	1
medical evaluation	1
vision screening to monitor for refractive errors and strabismus	1
monitoring of blood pressure in both arms	1
serum concentration of calcium	1
thyroid function and tsh level	1
evaluation for cataracts	1
the hearing loss in ws1 is typically non-progressive	1
hence, repeat audiogram would usually not be necessary	1
monitor for endocrine abnormalities:	1
hypogonadism at age 12-14 years	1
diabetes mellitus in the teens and later	1
hypothyroidism in the teens and later	1
dystonia may require monitoring by a neurologist	1
monitor hearing annually	1
regular follow-up of ophthalmologic abnormalities	1
ongoing follow-up with dermatologist	1
routine monitoring of any existing cardiac and/or renal abnormalities	1
regular hearing evaluations	1
no formal surveillance guidelines exist	1
the following are general considerations:	1
at least once a year:	1
chest x-rays or cts and sinus films	1
monitor and treat pulmonary complications:	1
bronchoscopic evaluations as indicated	1
perform annual endoscopic evaluation	1
at routine visits, monitor for the following:	1
chronic neutropenia	1
chronic diarrhea and resulting malnutrition	1
if present, screen for ova and parasites	1
autoimmune disorders with history, physical examination, and cbc	1
(syndrome-specific growth charts are not available	1
developmental progress should be monitored throughout infancy and childhood	1
periodic audiograms	1
the following routine monitoring is recommended:	1
assessment of developmental progress and cognitive abilities	1
screening for behavioral and psychiatric problems	1
monitoring during testosterone replacement therapy should include the following:	1
such testing should then be performed annually	1
ongoing psychosocial support	1
complete blood counts	1
liver and renal function	1
immune status	1
donor and recipient chimerism	1
